Abstract:Although heart failure due to a wide variety of pathological stimuli including myocardial infarction, pressure overload and volume overload is associated with cardiac hypertrophy, the exact reasons for the transition of cardiac hypertrophy to heart failure are not well defined. Since circulating levels of several vasoactive hormones including catecholamines, angiotensin II, and endothelins are elevated under pathological conditions, it has been suggested that these vasoactive hormones may be involved in the development of both cardiac hypertrophy and heart failure. At initial stages of pathological stimuli, these hormones induce an increase in ventricular wall tension by acting through their respective receptor-mediated signal transduction systems and result in the development of cardiac hypertrophy. Some oxyradicals formed at initial stages are also involved in the redox-dependent activation of the hypertrophic process but these are rapidly removed by increased content of antioxidants in hypertrophied heart. In fact, cardiac hypertrophy is considered to be an adaptive process as it exhibits either normal or augmented cardiac function for maintaining cardiovascular homeostasis. However, exposure of a hypertrophied heart to elevated levels of circulating hormones due to pathological stimuli over a prolonged period results in cardiac dysfunction and development of heart failure involving a complex set of mechanisms. It has been demonstrated that different cardiovascular abnormalities such as functional hypoxia, metabolic derangements, uncoupling of mitochondrial electron transport, and inflammation produce oxidative stress in the hypertrophied failing hearts. In addition, oxidation of catecholamines by monoamine oxidase as well as NADPH oxidase activation by angiotensin II and endothelin promote the generation of oxidative stress during the prolonged period by these pathological stimuli. It is noteworthy that oxidative stress is known to activate metallomatrix proteases and degrade the extracellular matrix proteins for the induction of cardiac remodeling and heart dysfunction. Furthermore, oxidative stress has been shown to induce subcellular remodeling and Ca2+-handling abnormalities as well as loss of cardiomyocytes due to the development of apoptosis, necrosis, and fibrosis. These observations support the view that a low amount of oxyradical formation for a brief period may activate redox-sensitive mechanisms, which are associated with the development of cardiac hypertrophy. On the other hand, high levels of oxyradicals over a prolonged period may induce oxidative stress and cause Ca2+-handling defects as well as protease activation and thus play a critical role in the development of adverse cardiac remodeling and cardiac dysfunction as well as progression of heart failure.

Oxidative stress-induced signal transduction pathways in cardiac myocytes: involvement of ROS in heart diseases.

Signal transduction of reactive oxygen species and mitogen-activated protein kinases in cardiovascular disease.

The role of reactive oxygen species in myocardial redox signaling and regulation

ROS and ROS-Mediated Cellular Signaling

[Role of Nrf2/HO-1 Signal Axis in the Mechanisms for Oxidative Stress-Relevant Diseases].

NADPH Oxidase and Cardiac Failure

The Role of Oxidative Stress in the Aging Heart

Upstream Reactive Oxidative Species (ROS) Signals in Exogenous Oxidative Stress‐induced Mitochondrial Dysfunction

Reactive oxygen species (ROS) as pleiotropic physiological signalling agents

Signaling Pathways Related to Oxidative Stress in Diabetic Cardiomyopathy

Mitochondrial reactive oxygen species production and elimination

Mitochondrial electron transport complex I is a potential source of oxygen free radicals in the failing myocardium

Signaling Pathways in Reactive Oxygen Species–Induced Cardiomyocyte Apoptosis

Oxidative stress and the role of redox signalling in chronic kidney disease

Reactive Oxygen Species and Oxidative Stress in Vascular-Related Diseases

Systematic Understanding of Pathophysiological Mechanisms of Oxidative Stress-Related Conditions—Diabetes Mellitus, Cardiovascular Diseases, and Ischemia–Reperfusion Injury

Pathological Roles of Oxidative Stress in Cardiac Microvascular Injury

Discovery of new therapeutic redox targets for cardioprotection against ischemia/reperfusion injury and heart failure

Reactive Oxygen Species in Cardiovascular Diseases: an Update

Oxidative Stress as A Mechanism for Functional Alterations in Cardiac Hypertrophy and Heart Failure